Incremental Prognostic Value of Cystatin C-Based Estimated Glomerular Filtration Rate in Patients With Acute Coronary Syndrome
Reviews in Cardiovascular Medicine · 28.10.2025 · 26 (10)
DOI: 10.31083/rcm39246 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 28.10.2025. Verfasst von Qiang Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Chinese Academy of Medical Sciences, Peking Union Medical College, 100029 B…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National High Level Hospital Clinical Research Funding, Beijing Research Ward Construction Clinical Research Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
The 2021 Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation, which incorporates both creatinine and cystatin C, provides enhanced estimation of glomerular filtration rate (eGFR) compared to creatinine-only equations. This study aimed to explore the incremental prognostic value of eGFR estimates in patients with acute coronary syndrome (ACS).
Method
This retrospective analysis evaluated 1400 ACS patients undergoing a percutaneous coronary intervention (PCI). The primary endpoint was defined as major adverse cardiovascular events (MACEs), a composite of all-cause death and nonfatal myocardial infarction (MI). The eGFR values were calculated using three equations: one based solely on serum creatinine (eGFRcr), another based only on cystatin C (eGFRcys), and a combined equation using both creatinine and cystatin C (eGFRcys-cr). Cox regression and the Kaplan–Meier analyses were employed to identify predictors of MACEs. The incremental prognostic value of the three eGFR equations on ACS outcomes was individually assessed.
Results
Over a median follow-up of 31.03 (27.34, 35.06) months, 135 (9.6%) patients experienced MACEs, including 99 (7.1%) deaths and 41 (2.9%) MIs. Lower eGFR values correlated with higher MACEs and the risk of death. Incorporating eGFRcys or eGFRcys-cr into the established risk model improved the predictive accuracy for MACEs. When compared to eGFRcr, eGFRcys-cr demonstrated greater capacity to reclassify the risk for MACEs (category-free continuous net reclassification improvement (cNRI)>0: 0.205 (0.011–0.397); p = 0.03; integrated discrimination improvement (IDI): 0.010 (0.002–0.019); p = 0.01), whereas eGFRcys did not demonstrate a similar effect.
Conclusion
The eGFR based on the 2021 CKD-EPI equation using both creatinine and cystatin C significantly improves risk prediction and reclassification in ACS patients compared with a creatinine-based equation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Chinese Academy of Medical Sciences, Peking Union Medical College, 100029 Beijing, China.
- Department of Cardiology, China-Japan Friendship Hospital, 100029 Beijing, China.
- Department of Cardiology, The Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, 610031 Chengdu, Sichuan, China.
ORCID-Profile: Qiang Chen, Jingang Zheng
Förderung
- National High Level Hospital Clinical Research Funding
- Beijing Research Ward Construction Clinical Research Project
- National Natural Science Foundation of China
- Capital's Founds for Health Improvement and Research
- Chinese Society of Cardiology's Foundation
- Chengdu High-level Key Clinical Specialty Construction Project
Zitieren
APA
Chen, Q., Li, Y., Chen, X., He, H., Xie, Y., Xu, Y., Cai, Y., Ye, T., Gao, Y., Xiong, S., Cai, L., & Zheng, J. (2025). Incremental Prognostic Value of Cystatin C-Based Estimated Glomerular Filtration Rate in Patients With Acute Coronary Syndrome. Reviews in Cardiovascular Medicine, 26(10). https://doi.org/10.31083/rcm39246
Vancouver
Chen Q, Li Y, Chen X, He H, Xie Y, Xu Y, et al. Incremental Prognostic Value of Cystatin C-Based Estimated Glomerular Filtration Rate in Patients With Acute Coronary Syndrome. Reviews in Cardiovascular Medicine. 2025;26(10). doi:10.31083/rcm39246
BibTeX
@article{Chen2025,
author = {Chen, Qiang and Li, Yike and Chen, Xu and He, Haoming and Xie, Yingying and Xu, Yonghui and Cai, Yue and Ye, Tao and Gao, Yanxiang and Xiong, Shiqiang and Cai, Lin and Zheng, Jingang},
title = {Incremental Prognostic Value of Cystatin C-Based Estimated Glomerular Filtration Rate in Patients With Acute Coronary Syndrome},
journal = {Reviews in Cardiovascular Medicine},
year = {2025},
volume = {26},
number = {10},
doi = {10.31083/rcm39246}
}
EUVIMED